Literature DB >> 10777371

Somatic mosaicism associated with a mild Alport syndrome phenotype.

K E Plant, E Boye, P M Green, D Vetrie, F A Flinter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777371      PMCID: PMC1734534          DOI: 10.1136/jmg.37.3.238

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  13 in total

1.  Germline mosaicism is a pitfall in the diagnosis of "sporadic" X-linked Alport syndrome.

Authors:  Takayuki Okamoto; Kandai Nozu; Kazumoto Iijima; Tadashi Ariga
Journal:  J Nephrol       Date:  2018-07-30       Impact factor: 3.902

2.  Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome.

Authors:  Xue Jun Fu; Kandai Nozu; Hiroshi Kaito; Takeshi Ninchoji; Naoya Morisada; Koichi Nakanishi; Norishige Yoshikawa; Hiromi Ohtsubo; Natsuki Matsunoshita; Naohiro Kamiyoshi; Chieko Matsumura; Nobuaki Takagi; Kohei Maekawa; Mariko Taniguchi-Ikeda; Kazumoto Iijima
Journal:  Eur J Hum Genet       Date:  2015-05-27       Impact factor: 4.246

3.  Identification of a novel COL4A5 mutation in a Chinese family with X-linked Alport syndrome using exome sequencing.

Authors:  Yi Guo; Jinzhong Yuan; Hui Liang; Jingjing Xiao; Hongbo Xu; Lamei Yuan; Kai Gao; Bin Wu; Yongchang Tang; Xiaorong Li; Hao Deng
Journal:  Mol Biol Rep       Date:  2014-02-13       Impact factor: 2.316

4.  A family with X-linked benign familial hematuria.

Authors:  Kazunari Kaneko; Sachiyo Tanaka; Masafumi Hasui; Kandai Nozu; Rafal Przybyslaw Krol; Kazumoto Iijima; Keisuke Sugimoto; Tsukasa Takemura
Journal:  Pediatr Nephrol       Date:  2010-03       Impact factor: 3.714

Review 5.  X-linked, COL4A5 hypomorphic Alport mutations such as G624D and P628L may only exhibit thin basement membrane nephropathy with microhematuria and late onset kidney failure.

Authors:  A Pierides; K Voskarides; M Kkolou; M Hadjigavriel; C Deltas
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

Review 6.  Expert consensus guidelines for the genetic diagnosis of Alport syndrome.

Authors:  Judy Savige; Francesca Ariani; Francesca Mari; Mirella Bruttini; Alessandra Renieri; Oliver Gross; Constantinos Deltas; Frances Flinter; Jie Ding; Daniel P Gale; Mato Nagel; Michael Yau; Lev Shagam; Roser Torra; Elisabet Ars; Julia Hoefele; Guido Garosi; Helen Storey
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

Review 7.  New insights into the generation and role of de novo mutations in health and disease.

Authors:  Rocio Acuna-Hidalgo; Joris A Veltman; Alexander Hoischen
Journal:  Genome Biol       Date:  2016-11-28       Impact factor: 13.583

8.  Assessment of the gene mosaicism burden in blood and its implications for immune disorders.

Authors:  Manuel Solís-Moruno; Anna Mensa-Vilaró; Laura Batlle-Masó; Irene Lobón; Núria Bonet; Tomàs Marquès-Bonet; Juan I Aróstegui; Ferran Casals
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

9.  The rate and spectrum of mosaic mutations during embryogenesis revealed by RNA sequencing of 49 tissues.

Authors:  Francesc Muyas; Luis Zapata; Roderic Guigó; Stephan Ossowski
Journal:  Genome Med       Date:  2020-05-27       Impact factor: 11.117

10.  Low frequency of parental mosaicism in de novo COL4A5 mutations in X-linked Alport syndrome.

Authors:  Ole Magnus Bjorgaas Helle; Torkild Høieggen Pedersen; Lilian Bomme Ousager; Mads Thomassen; Jens Michael Hertz
Journal:  Mol Genet Genomic Med       Date:  2020-08-18       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.